By Brian Houlihan, Dublin Hemp Museum | When Napoleon’s invaded Russia in 1812, the aim in part was to cut off Britain’s hemp supply, vital to the British war efforts as their large navy relied heavily on it for sailing and other uses. Read the story . . . and Meet Brian Houlihan at the Hemp2020 | Investment & Entrepreneurship Summit Oct. 19-20.
The post Hemp History: Invading Russia to halt Britain’s hemp supply appeared first on HempToday.
Western Australia officials have lifted the amount of THC allowable in industrial hemp to a full one percent, bringing the state in line with others in Australia – a global pace-setter in pushing THC limits higher.
Only Switzerland and Uruguay have a 1% upper limit for hemp while most nations around the world operate under rules setting the limit at 0.3%. European stakeholders are currently pushing EU officials to raise a member-state-wide 0.2% THC limit to the 0.3% level.
The changes in Western Australia come in amendments to the Industrial Hemp Act of 2004, and were passed by the State Parliament last week. The previous limit in WA was 0.35% THC.
“The cross-party support for these amendments is a sign of the wide recognition for the job-creating potential of this industry for regional WA,” Alannah MacTiernan, West Australia Agriculture and Food Minister said after the amendments passed. “These amendments will reduce risk for hemp growers and open up new opportunities in hemp seed as a food and drink product.”
Australia and New Zealand opened their markets for hemp foods in April 2017.
Australia-based Creso Pharma has inked an agreement with Pharmacare Europe to market and distribute its cannaQIX CBD product in the UK, the companies said in a release.
The deal could also lead to Pharmacare marketing other of Creso’s hemp-derived nutraceuticals products in the UK and other European markets under Pharmacare’s Naturopathica brand, the companies said. Pharmacare has more than 10,000 points of sale in Europe.
Creso announced in January that it would be entering the UK with cannaQIX and 50 nutraceutical products after signing a deal with Precision Healthcare for distribution in UK pharmacies and health food stores.
Pharmacare is a European subsidiary of Australia-based PharmaCare Laboratories that operates in Europe and the Middle East, across pharmacy, retail and online channels.
The UK launch of cannaQIX is planned for October 2018.
The Green Organic Dutchman Holdings Ltd. (TGOD) said it will buy 100% of HemPoland, maker of fast-moving CBD brand CannabiGold, in a deal that values the Elblag, Poland-based company at $15.5 million.
The agreement to acquire privately-held HemPoland comprises $7.75 million in cash and 1,968,323 in restricted TGOD shares currently valued at $7.75 million, TGOD said in a release. TGOD, based in Ancaster, Ontario, Canada, trades on the Toronto Stock Exchange and OTC in the U.S.
Additionally, the sellers can get performance based incentives of up to $12 million for delivery of $32 million of EBITDA in fiscal year 2021, according to the release.
TGOD also agreed to provide a $10.3 million cash investment “for rapid European expansion,” through funding R&D, drug development and global initiatives.
TGOD called the acquisition a “key component” in the company’s drive to expand its global distribution network. “Gaining market share with CBD products now, in the EU, with over 700 locations allows TGOD to establish immediate brand awareness across all verticals including infused beverages,” TGOD’s CEO Brian Athaide said, noting the deal opens “a gateway to Europe’s 750 million people.”
Small is beautiful at Obelisk Farm. That’s the spot in eastern Latvia where Andris Visnevskis and Debora Paulino have escaped the urban life and are living out their hemp dream.
“We did it mainly because of the kids,” Visnevskis said of the couple’s transition from the bustle of London to the clean air and pastoral life of the farm in 2013.
Having read about the properties of hemp seed oil, Andris and Debora purchased the run-down 2.5 hectare property – which includes an old farm house and several stone and wooden out buildings – with visions of entering the hemp food market.
While their initial idea was to grow hemp for its nutrient-rich seed, the couple quickly realized that their farm’s small size and lack of proper machinery called for an adjustment to the business model.
So in their second year at Obelisk, they added educational tours of the farm and launched a series of workshops in how to grow hemp, and how it can be used in food, paper, and for construction.
Hemp researcher and innovator Carl Martel of Carleton University, Ontario, Canada, will explain how carbonized hemp can be used to create energy storing hempcrete during the 8th Annual Symposium of the International Hemp Building Association (IHBA) Oct. 16-17 in Belgium.
Sponsorship and advertising opportunities in HempToday’s Special IHBA Edition
Martel, who has been researching industrial hemp since 2010, is among leading global hemp experts who will give updates on groundbreaking building projects, humanitarian initiatives and the latest developments in hemp-based construction during the event, to be held at Castle Hof Ter Loonst at Kampenhout near Brussels,
Formally trained as a geo-archaeologist, Martel has worked with a number of hemp companies across Canada and Australia. A grain quality post-harvest management systems expert, he is the co-inventor of a grain disinfection system currently deployed in those countries.
Martel’s recent focus has been on value added products from agricultural waste such as carbon foam for insulation, water filtration and desalination, and energy storage.
By Arne Verhoef | HempToday – In the “New Green Revolution” brought on by the resurgence of Cannabis, Asian hemp, with the most genetic diversity on the planet, has a decided advantage.
The original Green Revolution, also called the Third Agricultural Revolution (1960-c. 1979), brought rapid agricultural advances unparalleled in earlier periods. Agricultural inputs and new technologies helped increase production, but that Revolution’s biggest driving force was the genetic improvement of staple crops – high-yielding varieties developed through selective breeding.
Ironically, hemp escaped much of this development, handicapped by international narcotics conventions. Now, as the return of the Cannabis plant presents a “New Green Revolution” all its own, hemp is rapidly entering mainstream agriculture worldwide.
As the homeland of Cannabis, no place on Earth has a longer history with hemp than Asia. Cannabis occurs all over the continent, from Afghanistan and Vietnam, to Thailand and the Koreas. In India, there are probably as many hemp varieties as there are languages, while in some parts of China it would seem that every valley has its own unique crop.
In Mongolia near-wild populations of the plant exist, showcasing a staggering array of traits. Japan, with its long history of hemp use, has feral populations of their heritage strains to remind us of their pre-prohibition Cannabis richness.
Insured patients in the USA would pay up to $200 per month for CBD-based drug Epidiolex under a recent pricing announcement from the maker, UK-based GW Pharmaceuticals.
Epidiolex is the first cannabis-derived pharmaceutical to gain federal approval in the U.S. It was primarily developed for the treatment of two severe forms of epilepsy — Dravet Syndrome and Lennox-Gastaut Syndrome
For the uninsured, Epidiolex will cost about $32,500 per year, or just over $2,700 per month. That’s in line with other prescription drugs used to treat the same afflictions.
“We wanted to make sure we were pricing Epidiolex in such a way where the means to access . . . would be consistent with branded epilepsy drugs these patients already use,” said Justin Grover, GW’s CEO.
The price was determined mainly based on talks with insurance companies, according to Julian Gangolli, GW’s North American President.
Jacek Kramarz, Chief of Sales at Poland’s blue-chip CBD maker HemPoland, will talk about his experiences with a fast-moving startup that’s quickly expanded distribution of its CannabiGold brand into 20 markets over the last two years during “The Future of Medical Hemp” international industry summit and networking event Aug. 24-25 at HempToday Center in Poland.
Kramarz also will give a snapshot of the European CBD markets and run through the basics of CBD and its effects on humans.
Kramarz has been instrumental in the development of HemPoland, a vertically integrated producer that carefully manages the value chain from field to shelf, and which has worked its way into the leading ranks of European CBD purveyors. He previously worked in management consulting in Vienna where he coordinated international projects tackling complex changes in company ownership and restructuring. He is also a licensed securities broker
Only 1 accreditation remains for the Aug. 24-25 networking & intelligence gathering. The application period remains open through Aug. 17.
Representatives from the U.S. states of Colorado, Wisconsin and Maine are signed up to attend, as are delegates from Italy, Germany, China, Greece, Poland, Lithuania, Israel and the Czech Republic. Participants have the option of making a 15-minute presentation about their companies, startups or business plans.
The European Industrial Hemp Association (EIHA) has called on over-the-counter (OTC) clearinghouse Clearstream to shield five CBD companies who are in danger of losing post-trading services managed by the Luxembourg firm, a wholly owned subsidiary of Deutsche Börse.
More than 100 other cannabis companies are already excluded from a recently announced Clearstream provision that would stop the deposit of shares, due to take effect Sept. 28, 2018, by putting settlement restrictions on “companies primarily, directly or indirectly, active in the field of medical cannabis.”
Industry sources say the changes at Clearstream were caused by recently updated guidelines from the local controlling authority, the Commission de Surveillance Financier (CSSF), that are based on outdated cannabis laws in Luxembourg.
The five companies mentioned in the EIHA letter to the Deutsche Börse are Naturally Splendid Enterprises, New Age Farm, Inc., Nutritional High International Inc., all of Canada; and CannaVEST Corp. and CV Sciences, Inc., both of the USA.
“The companies . . . solely work with industrial hemp. Their range of products comprises food products made from industrial hemp (seeds) and/or neutraceuticals of hemp protein or cannabidiol (CBD), which is a non-psychoactive substance and therefore is not subject of the narcotic laws in European Countries (including Luxembourg),” EIHA wrote in the letter, noting several of the firms make products that are already on the market and are established as “medical” or “medicinal” in nature.
Colorado, USA-based Sana Packaging said it has delivered a round of first orders to customers in North America. The startup designs and develops plant-based hemp plastic packaging for the broader cannabis industry.
“We’re excited about our launch and we’re even more excited to provide the cannabis industry with some much needed differentiated, sustainable, and compliant packaging solutions,” Ron Basak-Smith, Sana’s co-founder and CEO, said in a release. “As rapidly growing and emerging industries, we believe the cannabis and industrial hemp industries have a responsibility to be platforms for positive social, economic, and environmental change.”
Sana said it uses 100% plant-based and chemical-free hemp plastic in its products.
The company is led by Basak-Smith and James Eichner, who met at the University of Colorado, Boulder’s MBA program. That’s where Sana got its spark, in a class project. After winning a university pitch competition, the enterprise got a boost from Canopy Boulder, a Colorado cannabis industry accelerator in 2017.
The post Colorado hemp plastic startup says it’s shipped first orders in N. America appeared first on HempToday.
The monopoly on medical knowledge previously held by governments, pharma companies and the medical establishment has now been broken forever due to technological advancements and the internet, according to Boaz Wachtel, an Israeli industry veteran who has launched two cannabis companies traded on the Australian Stock Exchange.
Wachtel will present “The Democratization of Knowledge: What it means for Medical Cannabis,” during “The Future of Medical Hemp” micro conference Aug. 24-25 at HempToday Center in Poland
Only 2 accreditations remain for the networking & intelligence gathering which is limited to 25 participants. Registrants have the option of making a 15-minute presentation about their companies, startups or business plans. The application period is open through Aug. 15.
Sign up for “The Future of Medical Hemp“
“The media tools available today can quickly fuel demand and further data sharing among patient groups in such a way that market estimates for CBD, especially because it is non-psychoactive and safe, are not far from future reality,” Wachtel said.
Canadian Greenfield Technologies Corp. (CGT) says it has developed the HempTrain Decortication System, specialized equipment based on high-speed kinematic technology that turns out intact structural bast fiber while capturing a clean microfiber stream and other hemp derivatives.
A turn-key installation of a HempTrain module with capacity 1 ton/hr is priced at $1,850,000; it includes a bale opener, main processing units, electrical and dust control – delivered, installed and commissioned., the Calgary-based company said in a release.
“This green microfiber stream significantly increases the value of the production, allowing for a high margin and short-time payback business model,” the company said. The cost of operating the technology is much lower per ton/hr of throughput than conventional decorticators, while producing much higher value materials, according to CGT.
The technology is an advancement over earlier generations of decorticators which employ a hammer mill, which damages bast fiber and causes attrition of hurd fiber.
GTC said it will begin hosting demonstrations of the decorticator in September.
Italy’s Ministry of Agriculture has proposed a special Council to support development of hemp value chains, and to ease the process of getting hemp products to market.
“If we want to market the resulting products from the cultivation of hemp or labeling them as food or give another destination, competent ministries must intervene to say what are the requirements and parameters to do so,” said Agriculture Commission President Filippo Gallinella. “It is absolutely necessary to involve all ministries and various commissions in the Council.”
Clarity around hemp foods and other products will give entrepreneurs and investors assurance they won’t be blindsided by a lack of rules if they want to start hemp businesses, Gallinella added.
The Council would join the Agriculture Ministry with the Ministries of Health, Economic Development, Interior and Environment, along with trade associations and research sector representatives with the aim of easing the process of getting hemp-based products to market. The initiative was launched during a recent conference by Rome-based Confagricoltura, a confederation of Italian farming enterprises. A wide range of stakeholders attended the conference.
“We have good laws,” said Diana Pallini, a member of the Confagricoltura Council, but clarity is needed in some areas.” She said creating innovative hemp products can help strenthen the “Made in Italy” brand.
A Colorado marijuana company is suing another firm in the state for patent infringement involving its cannabinoid-based medical product formula. United Cannabis Corp. (UCANN) of Golden filed the lawsuit in Denver U.S. District Court on Monday against Pure Hemp Collective of Conifer. The Denver Post reported the lawsuit seeks an injunction prohibiting Pure Hemp from […]
Colorado medical cannabis companies in patent dispute is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Health care needs to eschew a high-tech approach and go beyond the treatment of symptoms to attack the causes of chronic diseases rooted in current lifesyles. That’s the message Paulius Jaruševičius, Founder and Chairman of the Lithuania-based Lifestyle Medicine Association will bring to “The Future of Medical Hemp,” an international industry summit and networking event focused on CBD that is set Aug. 24-25 at HempToday Center in Poland.
Only 3 accreditations remain for the Aug. 24-25 networking & intelligence gathering. The application period is open through Aug. 15.
Jaruševičius’ presntation, “How phytocannabinoids work together with lifestyle change” will explore how lifestyles induce changes in gene expression, which is closely related to the human endocannabinoid system.
European blue-chip CBD brand CannabiGold is the host sponsor for “The Future of Medical Hemp,” where attendees will get an in-depth look at a wide range of topics related to CBD, including investment, product development & innovation, global medical hemp hot spots, the regulatory environment, biochemistry of cannabinoids, and cannabinoid production.
Representatives from Italy, Germany, China, Greece, Poland, USA, Lithuania, Israel and the Czech Republic are already signed on to attend the Summit. Participants have the option of making a 15-minute presentation about their companies, startups or business plans.
The Canadian Hemp Trade Alliance has named veteran agribusiness executive Ted Haney its Executive Director. Haney replaces part-time director Kim Shukla, who left the CHTA last May.
“Ted’s experience, insight and connections as a proven industry leader will help hemp produced and processed in Canada make its next leap forward as the industry pursues growth in food and expansion into the fibre, feed and natural health product markets around the world,” CHTA Executive Director Russ Crawford said in a statement.
Ted Haney
Haney is an international agribusiness executive with 30 years’ domestic and international management and marketing experience promoting Canadian products and services. He managed the Canada Beef Export Federation (CBEF) for 20 years, and previously served on the board of the Canadian Agri-Food Trade Alliance for eight years. His background is in strategic planning, corporate governance, finance, government relations and international market development.
CHTA is establishing an office in Calgary, Alberta where Haney will initially be based when he takes up his duties Aug. 1, Crawford said.
Everything seemed on track with the 2018 Farm Bill – expected to crack the U.S. market wide open – until somebody came up with another great idea to victimize the victims, that specialty of the Trump Administration and its enablers in Congress.
After a Senate-written Farm Bill carrying Republican Sen. Mitch McConnell’s all-important 2018 Hemp Farming Act passed with strong bi-partisan support, it then got hung up in the feeble, geriatric mind of Sen. Charles Grassley (Republican of Kansas) who, because he doesn’t understand the issues, insisted on attaching a draconian measure barring former drug felons from participating in hemp businesses.
In the back-door, back-stabbing, hands-on-the-throat process that requires both houses of Congress to agree on something, ugly things can happen. That McConnell, Our Great Hemp Leader of the Senate, caved to Grassley’s destructive amendment is therefore not surprising.
Down the Great American Hemp Highway: What’s that smell?
And anyway, the reality is that many states already ban felons from the hemp industry under rules put in place as pilot programs, state by state, sprouted up across the USA following passage of an earlier hemp bill included in the 2014 Farm Bill.
Rapidly expanding research has identified a growing number of aging-related chronic conditions that cannabis can treat. That’s both the result of record levels of investment – and an indicator of future growth, said Pavel Kubu, M.D., Founder & CEO of the Prague-based International Cannabis and Cannabinoid Institute (ICCI).
“Both business and government realize that this thriving industry has a future but the development must be based on conclusive research,” Kubu said.
Kubu will discuss that topic as one of the featured speakers at “The Future of Medical Hemp,” the next networking & intelligence event in HempToday’s annual Summit Series devoted to industrial hemp. Only 8 accreditations remain for the Aug. 24-25 gathering at HempToday Center in Poland; the summit is limited to 25 participants total. The application period remains open through Aug. 15.
Europe’s market of over 739 million people is poised to be the largest medical cannabis market in the world, Kubu noted.
As research continues apace, ongoing discovery is sure to address further chronic conditions of aging that may be treatable by cannabis, Kubu said. “As the list grows, so does the potential patient base,” he noted.
Second of Two Parts
Part One: A Hemp Manifesto for Africa
Despite starting research trials on the agronomic feasibility of hemp between 1994 and 1996 when the South African government started growing cannabis to make the THC isomer Dronabinol for the United States, South Africa has yet to properly legislate for hemp cultivation and use.
A study done by Camila Coogan, “The South African hemp story: Saviour Crop or Business as Usual?” details some of the trials and tribulations that has plagued the South African hemp industry. Many of the challenges stem from legislative barriers, while others stem from bad politics, differing stakeholder priorities and lack of any clear vision or consolidated efforts for a viable hemp industry.
Advocates, activists and commercial interests are challenging the lack of progress, and uniquely, cannabis prohibition is being challenged as unconstitutional and in violation of human-rights in SA courts. Meanwhile private stakeholders continue to advocate for legalization or de-regulation of cannabis, and are working to establish a hemp industry despite the legal and political challenges. A Cannabis Development Council of South Africa formed in late 2017 aims to facilitate industry growth.
The South African experience through 20 years can provide valuable insight to other countries on pitfalls and policy approaches to avoid as they slowly wake up to the potential of the crop:
Copyright 2019 - 2025. HempTalk.com is a division of MjLink.com, Inc.. All rights reserved. HempTalk
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!
